The effect of levodopa on the mortality of patients with Parkinson's disease was investigated in 349 patients treated with levodopa or levodopa combined with decarboxylase inhibitor during 1969-1975 inclusive. During the study period, 61 patients died. The expected mortality was 32.99 resulting in a
Mortality and cancer incidence in patients with Parkinson's disease
β Scribed by Yuko Minami; Reiko Yamamoto; Mitsuaki Nishikouri; Akira Fukao; Shigeru Hisamichi
- Book ID
- 106096162
- Publisher
- Springer
- Year
- 2000
- Tongue
- English
- Weight
- 116 KB
- Volume
- 247
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Do Other Studies Show Increased Mortality Due to Selegiline? Other than the UK study, no clinical trial to date has shown an increase in mortality in association with the use of selegiline. In the Sindepar study, a cohort of I01 untreated P D patients participated in a 14-month prospective, ran
## Background: The objective of this study was to examine the clinical outcome and mortality of long-term deep brain stimulation of the subthalamic nucleus in advanced parkinson's disease. ## Methods: We included all 144 patients (mean age, 60.3 years; mean disease duration, 11.0 years) treated i